Screening for hazardous alcohol use and depressive symptomatology among HIV-infected patients in Nigeria: Prevalence, predictors, and association with adherence

Journal of the International Association of Physicians in AIDS Care

Volumn 9, Issue 4, 2010, Pages 218-226

  Farley, John ^a   Miller, Erin ^a   Zamani, Andrew ^b   Tepper, Vicki ^a   Morris, Chester ^c   Oyegunle, Modupe ^a   Lin, Maria ^a   Charurat, Manhattan ^a   Blattner, William ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ABUJA   (Nigeria)

^c JHPIEGO   (United States)

Author keywords

adherence; alcohol; depression; HIV Infection; Nigeria

Indexed keywords

ANTIRETROVIRUS AGENT; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADULT; ALCOHOLISM; ARTICLE; CENTER FOR EPIDEMIOLOGICAL STUDIES DEPRESSION SCALE; DEPRESSION; EDUCATIONAL STATUS; EMPLOYMENT; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERVIEW; MAJOR CLINICAL STUDY; MALE; NIGERIA; PATIENT COMPLIANCE; PHARMACY; PRIORITY JOURNAL; VIROTHERAPY; ADOLESCENT; MASS SCREENING; METHODOLOGY; PATHOLOGY; PREDICTION AND FORECASTING; PREVALENCE; PSYCHOLOGICAL RATING SCALE; QUESTIONNAIRE;

ADOLESCENT; ADULT; ALCOHOLISM; ANTI-HIV AGENTS; DEPRESSION; FEMALE; HIV INFECTIONS; HUMANS; MALE; MASS SCREENING; MEDICATION ADHERENCE; NIGERIA; PREDICTIVE VALUE OF TESTS; PREVALENCE; PSYCHIATRIC STATUS RATING SCALES; QUESTIONNAIRES; YOUNG ADULT;

EID: 77958160898     PISSN: 15451097     EISSN: 15570886     Source Type: Journal    
DOI: 10.1177/1545109710371133     Document Type: Article

References (45)

1. World Health Organization. HIV/AIDS epidemiological surveillance report for the WHO African region: 2007 update. http://www.afro.who.int/aids/ publications/OMS%20HIVAIDS%20in%20Africa%202007-FINAL.pdf. Accessed August 11, 2009.
2. World Health Organization. Towards universal access: scaling up priority HIV/AIDS interventions in the health sector, progress report June 2008. http://www.who.int/hiv/pub/2008progressreport/en/index.html. Accessed August 11, 2009.
3. Joint United Nations Programme on HIV / Aids. Country responses: Nigeria. http://www.unaids.org/en/CountryResponses/Countries/nigeria.asp. Accessed January 8, 2010.
4. Nigerian National Agency for the Control of AIDS. Nigeria UNGASS Report, 2007. http://www.data.unaids.org/pub/Report/2008/nigeria-2008-country-progress- report-en.pdf. Accessed January 8, 2010.
5. Mill EJ, Nachega JB, Buchan I., et al. Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis. JAMA. 2006 ; 296 (6). 679-690.
6. Rosen S., Fox MP, Gill CJ Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review. PLoS Med. 2007 ; 4 (10). e298 ; doi:10.1371/journal.pmed.0040298.
7. Bell DJ, Kapitao Y., Sikwese R., van Oosterhout JJ, Lalloo DG Adherence to antiretroviral therapy in patients receiving free treatment from a government hospital in Blantyre, Malawi. J Acquir Immune Defic Syndr. 2007 ; 45 (5). 560-563.
8. Vriesendorp R., Cohen A., Kristanto P., et al. Adherence to HAART therapy measured by electronic monitoring in newly diagnosed HIV patients in Botswana. Eur J Clin Pharmacol. 2007 ; 63 (12). 1115-1121.
9. Muyingo SK, Walker AS, Reid A., et al. Patterns of individual and population-level adherence to antiretroviral therapy and risk factors for poor adherence in the first year of the DART trail in Uganda and Zimbabwe. J Acquir Immune Defic Syndr. 2008 ; 48 (4). 468-475.
10. Goldman JD, Cantrell RA, Mulaenga LB, et al. Simple adherence assessments to predict virologic failure among HIV-infected adults with discordant immunologic and clinical responses to antiretroviral therapy. AIDS Res Hum Retroviruses. 2008 ; 24 (8). 1031-1035.
11. Chi BH, Cantrell RA, Zulu I., et al. Adherence to first line antiretroviral therapy affects non-virologic outcomes among patients on treatment for more than 12 months in Lusaka, Zambia. Int J pidemiol. 2009 ; 38 (3). 746-756.
12. Unge C., Sodergard B., Ekstrom AM, et al. Challenges for scaling up ART in a resource-limited setting: a retrospective study in Kibera, Kenya. J Acquir Immune Defic Syndr. 2009 ; 50 (4). 397-342.
13. Charurat ME, Oyegunle M., Benjamin R., et al. Patient retention and adherence to antiretrovirals in a large antiretroviral therapy program in Nigeria: a longitudinal analysis for risk factors. PLoS Med. 2010 ; in press.
14. Galvan FH, Bing EG, Fleishman JA, et al. The prevalence of alcohol consumption and heavy drinking among people with HIV in the United States: results from the HIV Cost and Services Utilization Study. J Stud Alcohol. 2002 ; 63 (2). 179-186.
15. Kalichman SC, Simbayi LC, Kaufman M., Cain D., Jooste S. Alcohol use and sexual risks for HIV/AIDS in sub-Saharan Africa: systematic review of empirical findings. Prev Sci. 2007 ; 8 (2). 141-151.
16. Chinyadza E., Moyo IM, Katsumbe TM, et al. Alcohol problems among patients attending five primary health care clinics in Harare City. Cent Afr J Med. 1993 ; 39 (2). 26-32.
17. Shaffer DN, Njeri R., Justice AC, Odero WW, Tierney WM Alcohol abuse among patients with and without HIV infection attending public clinics in western Kenya. East Afr Med J. 2004 ; 81 (11). 594-598.
18. Mbulaiteye SM, Ruberantwari A., Nakiyingi JS, Carpenter LM, Kamali A., Whitworth JA Alcohol and HIV: a study among sexually active adults in rural southwest Uganda. Int J Epidemiol. 2000 ; 29 (5). 911-915.
19. Myer L., Smit J., Le Roux L., Parker S., Stein DJ, Seedat S. Common mental disorders among HIV-infected individuals in South Africa: prevalence, predictors, and validation of brief psychiatric rating scales. AIDS Patient Care STDS. 2008 ; 22 (2). 147-158.
20. Chander G., Himelhoch S., Moore RD Substance abuse and psychiatric disorders in HIV-positive patients. Drugs. 2006 ; 66 (6). 769-789.
21. Hendershot CS, Stoner SA, Pantalone DW, Simoni JM Alcohol use and antiretroviral adherence: review and meta-analysis. J Acquir Immune Defic Syndr. 2009 ; 52 (2). 180-202.
22. Rabkin JG HIV and depression: 2008 review and update. Curr HIV/AIDS Rep. 2008 ; 5 (4). 163-171.
23. Horberg MA, Silverburg MJ, Hurley LB, et al. Effects of depression and selective serotonin reuptake inhibitor use on adherence to highly active antiretroviral therapy and on clinical outcomes in HIV-infected patients. J Acquir Immune Defic Syndr. 2008 ; 47 (3). 384-390.
24. Yun LW, Maravi M., Kobayashi JS, Barton PL, Davidson AJ Antidepressant treatment improves adherence to antiretroviral therapy among depressed HIV-infected patients. J Acquir Immune Defic Syndr. 2005 ; 38 (4). 432-438.
25. Byakika-Tusiime J., Crane J., Oyugi JH, et al. Longitudinal antiretroviral adherence in HIV+ Ugandan parents and their children initiating HAART in the MTCT-Plus family treatment model: role of depression in declining adherence over time. AIDS Behav. 2009 ; 13 (suppl 1). S82 - S91.
26. Amberbir A., Woldemichael K., Getachew S., Girma B., Deribe K. Predictors of adherence to antiretroviral therapy among HIV-infected persons: a prospective study in Southwest Ethiopia. BMC Public Health. 2008 ; 8: 265. doi:10.1186/1471-2458-8-265.
27. Saunders JB, Aasland OG, Babor TF, De la Fuente JR, Grant M. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption II. Addiction. 1993 ; 88 (6). 791-804.
28. Conigrave KM, Hall WD, Saunders JB The AUDIT questionnaire: choosing a cut-off score. Addition. 1995 ; 90 (10). 1349-1356.
29. Bohn MJ, Babor TF, Kranzler HR The alcohol use identification test (AUDIT): validation of a screening instrument for use in medical settings. J Stud Alcohol. 1994 ; 56 (4). 423-432.
30. Radloff LS The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas. 1977 ; 1 (3). 386-401.
31. Poupard M., Gueye NF, Thiam D., et al. Quality of life and depression among HIV-infected patients receiving efavirenz- or protease inhibitor-based therapy in Senegal. HIV Med. 2007 ; 8 (2). 92-95.
32. Kaharuza FM, Bunnell R., Moss S., et al. Depression and CD4 cell count among persons with HIV infection in Uganda. AIDS Behav. 2006 ; 10 (4 suppl). S105 - S111.
33. Pretorius TB Cross-cultural applications of the Centre for Epidemiological Studies depression scale: a study of black South African students. Psychol Rep. 1991 ; 69 (3 pt 2). 1179-1185.
34. Wessiman MM, Prusoff B., Newberry P. Comparison of the CES-D With Standardized Depression Rating Scales at Three Points in Time. Yale University Technical Report. Yale University Press ; New Haven, CT: Yale University Press ; 1975.
35. Schein RL, Roenig HG The Center for Epidemiological Studies-Depression (CES-D) Scale: assessment of depression in the medically ill elderly. Int J Geriatr. 1997 ; 12 (4). 436-446.
36. Lyness JM, Noel TK, Cox C., King DA, Conwell Y., Caine ED Screening for depression in elderly primary care patients: a comparison of the Center for Epidemiologic Studies-Depression Scale and the Geriatric Depression Scale. Arch Intern Med. 1997 ; 157 (4). 449-454.
37. Adewuya A. Validation of the Alcohol Use Disorders Identification Test (AUDIT) as a screening tool for alcohol-related problems among Nigerian University students. Alcohol Alcohol. 2005 ; 40 (6). 575-577.
38. Gureja O., Obikoya B., Ikuesan BA Alcohol abuse and dependence in an urban primary care clinic in Nigeria. Drug Alcohol Depend. 1992 ; 30 (2). 163-167.
39. Adewuya AO, Afolabi MO, Ola BA, et al. Relationship between depression and quality of life in persons with HIV infection in Nigeria. Int J Psychiatry Med. 2008 ; 38 (1). 43-51.
40. Olley BO, Seedat S., Stein DJ Persistence of psychiatric disorders in a cohort of HIV/AIDS patients in South Africa: a 6-month follow-up study. J Psychosom Res. 2006 ; 61 (4). 479-484.
41. Lima VD, Geller J., Bangsberg DR, et al. The effect of adherence on the association between depressive symptoms and mortality among HIV-infected individuals first initiating HAART. AIDS. 2007 ; 21 (9). 1175-1183.
42. Saberi P., Caswell N., Amodio-Groton M., Alpert P. Pharmacy refill measure of adherence to efavirenz can predict maintenance of HIV viral suppression. AIDS Care. 2008 ; 20 (6). 741-745.
43. Bisson GP, Gross R., Bellamy S., et al. Pharmacy refill adherence compared with CD4 count changes for monitoring HIV-infected adults on antiretroviral therapy. PLoS Med. 2008 ; 5 (5). e109.
44. Goldman JD, Cantrell RA, Mulengta LB, et al. Simple adherence assessments to predict virologic failure among HIV-infected adults with discordant immunologic and clinical responses to antiretroviral therapy. AIDS Res Hum Retroviruses. 2008 ; 24 (8). 1031-1035.
45. Kalichman SC, Rompa D., Cage M. Distinguishing between overlapping somatic symptoms of depression and HIV disease in people living with HIV-AIDS. J Nerv Ment Dis. 2000 ; 188 (10). 662-670.